Skip to main content
Caplight Logo









Hyalex Orthopaedics

Hyalex Orthopaedics

Private
Lexington, MassachusettsHealthcare & Life Scienceshttps://hyalex.com/

Last Round

Series B

Oct 2, 2024

Est. Valuation

$68.9M

Total Funding Raised

$64.9M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Hyalex Orthopaedics is a medical technology company that develops a biomimetic synthetic cartilage platform for the treatment of diseased and damaged joints.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

synthetic cartilageknee implantorthopaedic devicejoint replacementbiomaterialsmedical deviceorthopaedicssports medicineimplantable devicecartilage repairmedtechortho implantclinical trialsjoint repair

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hyalex Orthopaedics Comparables

Compare Hyalex Orthopaedics with similar companies based on industry and business-model similarity.

Hyalex Orthopaedics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sparta Biomedical
84%
BioPoly LLC
83%
Askel Healthcare
78%

Hyalex Orthopaedics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 2, 2024
Series A ExtensionMar 28, 2019
Series AMay 31, 2017

Key People

Founding team and executive leadership

Carl Vause

Chief Executive Officer, President, Director

Executive Team

David Neafus

Chief Financial Officer

Executive Team

Hyalex Orthopaedics Investors

Notable investors and investment history

Hyalex Orthopaedics investors
InvestorRounds
Osage University PartnersSeries A Extension, Series A
Canaan PartnersSeries A Extension, Series A
DSM VenturingSeries A, Series A Extension
Johnson & Johnson Innovation – JJDCSeries A
Johnson & Johnson Innovation - JJDC, Inc.Series A, Series A Extension
Treo VenturesSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 34% MoM, from 2.2K to 3K.

  • Oct 14, 2025

    Will present clinical study data at the ICRS Congress 2025.

Hyalex Orthopaedics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hyalex Orthopaedics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hyalex Orthopaedics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLexington, Massachusetts
Employee Range23
Year Founded2017
Last FundingOct 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?